|
Language of Instruction
|
English
|
|
Level of Course Unit
|
Master's Degree
|
|
Department / Program
|
BIOENGINEERING
|
|
Type of Program
|
Formal Education
|
|
Type of Course Unit
|
Elective
|
|
Course Delivery Method
|
Face To Face
|
|
Objectives of the Course
|
This course aims to introduce students to the field of genome editing technologies. Students will explore the historical development of genome editing tools including Zinc Finger Nucleases (ZNF), Transcription Activator-Like Effector Nucleases (TALEN), and CRISPR/Cas9. The course will provide an in-depth understanding of CRISPR experimental design including sgRNA selection, vector-based and vector-free systems, screening strategies, efficiency, specificity, and safety. The role of CRISPR-based genome editing in treating cancer and monogenic diseases will be discussed, alongside its ethical implications.
|
|
Course Content
|
The course will begin with the historical development and comparison of genome editing technologies such as ZNF, TALEN, and CRISPR/Cas9. It will then cover CRISPR experimental design strategies including target site selection, sgRNA design, vector-based and vector-free delivery systems, screening approaches, and methods to evaluate efficiency, specificity, and safety. Students will learn about the therapeutic applications of CRISPR/Cas9 in treating cancer and monogenic diseases, and how it is used to dissect gene functions. The course will conclude with a discussion on the ethical dimensions of genome editing.
|
|
Course Methods and Techniques
|
The course will employ lectures, literature review, case studies, group discussions, and debates on ethical dilemmas. Students will also design mock CRISPR experiments and analyze scientific publications related to genome editing.
|
|
Prerequisites and co-requisities
|
None
|
|
Course Coordinator
|
None
|
|
Name of Lecturers
|
Associate Prof.Dr. Oktay İ. Kaplan oktay.kaplan@agu.edu.tr
|
|
Assistants
|
None
|
|
Work Placement(s)
|
No
|
Recommended or Required Reading
|
Resources
|
Ceccaldi, R., Rondinelli, B., & D’Andrea, A. D. (2016). Repair pathway choices and consequences at the double-strand break. Nature Reviews Molecular Cell Biology, 17, 5–18. Chang, H. H. Y. et al. (2017). Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nature Reviews Molecular Cell Biology, 18, 495–506. Komor, A. C., Badran, A. H., & Liu, D. R. (2017). CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes. Cell, 168(1–2), 20–36. Qi, L. S., et al. (2013). Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell, 152(5), 1173–1183. Anzalone, A. V., Koblan, L. W., & Liu, D. R. (2020). Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nature Biotechnology, 38, 824–844. Liu, Y. et al. (2020). Optimizing prime editing by maximizing pegRNA efficiency and minimizing indels. Nature Biotechnology Dever, D. P. et al. (2016). CRISPR/Cas9 ß-globin gene targeting in human haematopoietic stem cells. Nature, 539, 384–389. Esrick, E. B., & Williams, D. A. (2020). Safety and efficacy of gene therapy for ß-thalassemia and sickle cell disease. Blood, 136(3), 273–282. Regalado, A. (2018). The CRISPR baby scandal gets worse by the day. MIT Technology Review
|
|
Course Notes
|
What is genome editing?
Early gene-editing tools: ZFNs and TALENs
Discovery and development of CRISPR-Cas systems
Milestones in CRISPR history (Doudna & Charpentier, Zhang lab)
|
|
Documents
|
nope
|
|
Assignments
|
Nope
|
|
Exams
|
Nope
|
Course Category
|
Mathematics and Basic Sciences
|
%50
|
|
|
Engineering
|
%0
|
|
|
Engineering Design
|
%0
|
|
|
Social Sciences
|
%0
|
|
|
Education
|
%0
|
|
|
Science
|
%0
|
|
|
Health
|
%50
|
|
|
Field
|
%0
|
|
|